GSK

Fierce Pharma

FDA approves leucovorin without clinical trial—but not for autism

The FDA has used real-world data to approve leucovorin to treat cerebral folate deficiency in patients who have a confirmed variant in the FOLR1 gene.

Angus Liu , Darren Incorvaia Mar 10, 2026 9:00am

Breakout Ventures launches $114M AI-focused fund

Mar 10, 2026 7:00am

Alfasigma's $690M deal for GSK itch drug awaiting FDA decision

Mar 9, 2026 6:55am

GSK pays $950M for Canadian biotech with Winrevair-like PAH drug

Feb 25, 2026 4:28am

GSK explores frontiers of siRNA with $1B deal for 2 drugs

Feb 24, 2026 8:10am

GSK inks 5-year deal with Jackson Lab for neuro research

Feb 18, 2026 3:30pm